AniCura Belgium Revenue and Competitors
Employee Data
- AniCura Belgium has 36 Employees.
- AniCura Belgium grew their employee count by 24% last year.
AniCura Belgium's People
Name | Title | Email/Phone |
---|
AniCura Belgium Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 36 | 24% | N/A | N/A |
What Is AniCura Belgium?
AniCura is a large European network of animal hospitals, clinics and practices specialised in high-quality veterinary care for companion animals. Born out of the idea that sharing resources and knowledge creates opportunities for better veterinary care, the company was established in 2011 as the first merger of companion animal hospitals in the Nordic region. Today, AniCura treats yearly more than 3 million pets from more than 300 European locations with 6000 passionate professionals. Since 2020 AniCura also has locations in Belgium and is expanding rapidly there. Through collaboration, a shared infrastructure, modern equipment and advanced specializations AniCura is continuously improving its quality and service, making it a valued partner for pet owners and referring veterinarians across Europe. AniCura offers everything from preventive care to advanced diagnostics, internal medicine, intensive care, surgery and orthopedics. But also physiotherapy, dietary advice, selected pet food and care products. Since 2018, AniCura is part of Mars Veterinary Health, a family-owned company focused on veterinary care. mars.com/legal-netherlands mars.com/privacy-policy-netherlands mars.com/legal-france mars.com/privacy-policy-belgium
keywords:N/AN/A
Total Funding
36
Number of Employees
N/A
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 36 | 33% | N/A |
#2 | $3.7M | 36 | 13% | N/A |
#3 | N/A | 39 | -26% | N/A |
#4 | $6.4M | 40 | 67% | N/A |
#5 | $11.4M | 44 | -4% | N/A |